Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update regarding Jinghua Weikang Capsule for reflux esophagitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jinghua Weikang Capsule

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Reflux Esophagitis | Phase 4 | Status: UNKNOWN